Seroatlas · Human Serome Atlas

OAZ2

Ornithine decarboxylase antizyme 2

Also known as: OAZ2_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
O95190
Gene
OAZ2
Ensembl
ENSG00000180304
Chromosome
15
Canonical length
189 aa
Protein class
Predicted intracellular proteins
Subcellular location
Golgi apparatus
Quaternary structure
Homodimer

OverviewNCBI Gene

The protein encoded by this gene belongs to the ornithine decarboxylase antizyme family, which plays a role in cell growth and proliferation by regulating intracellular polyamines. Expression of antizymes requires +1 ribosomal frameshifting, which is enhanced by high levels of polyamines. Antizymes in turn bind to and inhibit ornithine decarboxylase (ODC), the key enzyme in polyamine biosynthesis; thus, completing the auto-regulatory circuit. This gene encodes antizyme 2, the second member of the antizyme family. Like antizyme 1, antizyme 2 has broad tissue distribution, inhibits ODC activity and polyamine uptake, and stimulates ODC degradation in vivo; however, it fails to promote ODC degradation in vitro. Antizyme 2 is expressed at lower levels than antizyme 1, but is evolutionary more conserved, suggesting it likely has an important biological role. Studies also show different subcellular localization of antizymes 1 and 2, indicating specific function for each antizyme in discrete compartments of the cell. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Dec 2014]

Canonical amino-acid sequenceUniProt

189 residues, UniProt reviewed canonical sequence.

>O95190|OAZ2
     1  MINTQDSSIL PLSNCPQLQC CRHIVPGPLW CSDAPHPLSK IPGGRGGGRD PSLSALIYKD
    61  EKLTVTQDLP VNDGKPHIVH FQYEVTEVKV SSWDAVLSSQ SLFVEIPDGL LADGSKEGLL
   121  ALLEFAEEKM KVNYVFICFR KGREDRAPLL KTFSFLGFEI VRPGHPCVPS RPDVMFMVYP
   181  LDQNLSDED

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against OAZ2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.43
Highest tissue expression
195 nTPM

Expression across tissuesHPA

Tissue

  • skeletal muscle: 195 nTPM
  • tongue: 142 nTPM
  • retina: 114 nTPM
  • cerebral cortex: 110 nTPM
  • amygdala: 110 nTPM
  • midbrain: 106 nTPM

Single-cell type

  • early spermatids: 400 nCPM
  • neutrophils: 290 nCPM
  • late primary spermatocytes: 174 nCPM
  • müller glia: 169 nCPM
  • early primary spermatocytes: 168 nCPM
  • epicardial cells: 164 nCPM

Immune cell

  • neutrophil: 420 nTPM
  • eosinophil: 269 nTPM
  • intermediate monocyte: 248 nTPM
  • non-classical monocyte: 211 nTPM
  • classical monocyte: 146 nTPM
  • total PBMC: 116 nTPM

Brain region

  • midbrain: 78 nTPM
  • thalamus: 78 nTPM
  • white matter: 78 nTPM
  • hypothalamus: 77 nTPM
  • spinal cord: 76 nTPM
  • medulla oblongata: 74 nTPM

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.76
gnomAD pLI
0.31
gnomAD missense Z
1.27
DepMap mean gene effect
0.03
DepMap dependency class
none

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of OAZ2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads OAZ2 as an antibody target. Whether an autoantibody or antibody against OAZ2 could matter depends on whether native OAZ2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

OAZ2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label OAZ2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/OAZ2. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...